NeuroMetrix (NURO) Competitor Comparison
We are evaluating the key criteria listed to compare NeuroMetrix (NURO) against its competitors in the Medical Instruments & Supplies industry.
Market Capitalization
44 / 44Gross Profits
36 / 40Total Revenue
39 / 43EBITDA
30 / 44Free Cashflow
31 / 44Quick Ratio
2 / 44Earnings per Share
41 / 44Dividend yield
0 / 13Total Cash
33 / 44Performance 3 years
43 / 44Performance 5 years
39 / 44Performance 10 years
42 / 44Linearity 3 years
40 / 43Linearity 5 years
26 / 44Linearity 10 years
27 / 43Total Rank
18 / 44Dividend Rank
29 / 44Valuation Rank
42 / 44Piotroski Rank
30 / 44Muliplier Rank
17 / 44Valuation Rank - NURO ranking 42 / 44
Obligatory risk notice
We would like to point out that the contents of this website are for general information purposes only and do not constitute recommendations for the purchase or sale of specific financial instruments, and therefore do not constitute investment advice. In particular, marketstorylabs.com and its creators cannot assess the extent to which information / recommendations made on the pages correspond to your investment objectives, your risk tolerance and your ability to bear losses. Therefore, if you make any investment decisions based on information on the site, you do so solely on your own responsibility and at your own risk. This in turn means that neither marketstorylabs.com nor its creators are liable for any losses incurred as a result of investment decisions based on the information on the marketstorylabs.com website or other media used.